Stocks and Investing
Stocks and Investing
Tue, September 13, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, September 12, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeff Jones Maintained (VTYX) at Buy with Increased Target to $65 on, Sep 12th, 2022
Jeff Jones of Oppenheimer, Maintained "Ventyx Biosciences, Inc." (VTYX) at Buy with Increased Target from $40 to $65 on, Sep 12th, 2022.
Jeff has made no other calls on VTYX in the last 4 months.
There are 4 other peers that have a rating on VTYX. Out of the 4 peers that are also analyzing VTYX, 0 agree with Jeff's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jeff
- Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $45 on, Wednesday, September 7th, 2022
- Emily Bodnar of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $36 on, Thursday, September 1st, 2022
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 17th, 2022
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $63 on, Tuesday, August 16th, 2022
Contributing Sources